Asthma is a major public health problem worldwide and is associated with excess morbidity, mortality, and economic costs associated with lost productivity. The National Asthma Education and Prevention Program has released the 2020 Asthma Guideline Update with updated evidence-based recommendations for tr...
This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the risk of asthma attacks. It does not cover managing severe asthma or acute asthma attacks. The investment ...
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Adrenergic beta-2 Receptor Agonists/therapeutic use,
Aminopyridines/therapeutic use,
Benzamides/therapeutic use,
Cyclopropanes/therapeutic use,
Fluoroquinolones/therapeutic use,
Macrolides/therapeutic use,
Muscarinic Antagonists/therapeutic use,
Phosphodiesterase 4 Inhibitors/therapeutic use,
Disease Progression,
Pulmonary Disease, Chronic Obstructive,
Pulmonary Disease, Chronic Obstructive/drug therapy,
Pulmonary Disease, Chronic Obstructive/physiopathology,
Secondary Prevention/standards,
Adrenergic beta-2 Receptor Agonists,
Aminopyridines,
Benzamides,
Cyclopropanes,
Fluoroquinolones,
Macrolides,
Muscarinic Antagonists,
Phosphodiesterase 4 Inhibitors
This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have....
